The Association between Autoantibodies and Peripheral Neuropathy in Lupus Nephritis

Abstract EN

Background and Aim.

The sensitivity and specificity of biomarkers used for predicting peripheral neuropathy in patients with systemic lupus erythematosus (SLE) and nephritis (SLE-LN) remain unsatisfactory.

This study aimed to determine the autoantibodies levels in SLE-LN patients with peripheral neuropathy.

Methods.

Data of 559 SLE-LN patients were collected retrospectively, including titers of autoantibodies, electrodiagnostic studies, and clinical manifestations.

Results.

The neurologic manifestations of the SLE-LN patients were diverse and nonspecific.

The prevalence rate of peripheral polyneuropathy was 2.68%, of which about 73.33% was mixed sensory-motor polyneuropathy.

Numbness and functional gastrointestinal problems were the most prevalent symptoms and these were noted in every subtype of peripheral neuropathy.

Among all the serology markers, anti-Ro was significantly associated with neuropathy related to SLE (P=0.009).

Conclusion.

Peripheral neuropathy among LN patients is rare and may be easily overlooked.

This study demonstrated that positive anti-Ro antibody may imply neuropathy in LN patients.

Thus, anti-Ro can be considered a biomarker that should be added to the panel of conventional autoantibodies in LN patients.